跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
鄒 居霖
副教授
,
腎臟內科
成員
,
臺北醫學大學泌尿腎臟研究中心
https://orcid.org/0000-0002-9695-1067
電子郵件
chulin.chou
tmu.edu
tw
h-index
713
引文
15
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2010
2025
每年研究成果
概覽
指紋
網路
專案
(2)
研究成果
(51)
類似的個人檔案
(6)
指紋
查看啟用 Chu-Lin Chou 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
100%
Cohort Study
86%
Hemodialysis
80%
Fructose
52%
End Stage Renal Disease
43%
Acute Kidney Failure
39%
Metabolic Syndrome X
36%
Diabetes Mellitus
29%
All Cause Mortality
23%
Obesity
22%
Dipeptidyl Carboxypeptidase Inhibitor
22%
Angiotensin Receptor Antagonist
22%
Adverse Outcome
20%
Nephrotoxicity
18%
Renin Inhibitor
18%
Insulin Resistance
17%
Cardiovascular Disease
17%
Case-Control Study
17%
Aliskiren
17%
Acetylsalicylic Acid
17%
Arteriovenous Fistula
17%
Brain Hemorrhage
17%
Coronary Artery Disease
14%
Kidney Disease
14%
Coronary Artery Atherosclerosis
13%
Fibrosis
11%
Angiotensin II
11%
Mouse
11%
Calcium Channel Blocker
11%
Metformin
11%
Adverse Event
10%
Diuretic Agent
10%
Retrospective Study
10%
Endothelial Dysfunction
10%
Activating Transcription Factor 3
9%
Randomized Controlled Trial
9%
Congestive Heart Failure
9%
Injury
9%
Atrial Fibrillation
9%
Glucose Intolerance
9%
Amlodipine
9%
Brain Ischemia
9%
Therapeutic Effect
8%
Polyunsaturated Fatty Acid
8%
Antithrombotic Therapy
8%
Neurotoxicity
8%
Open Angle Glaucoma
8%
Bacterial Peritonitis
8%
Gout
8%
Bacterial Infection
8%
Medicine and Dentistry
Chronic Kidney Disease
72%
Cohort Analysis
64%
Hemodialysis
57%
Retrospective Cohort Study
28%
Acute Kidney Injury
27%
Fructose
26%
Hazard Ratio
23%
Arteriovenous Fistula
17%
Metabolic Syndrome
17%
End Stage Renal Disease
16%
Insulin Resistance
15%
Coronary Artery Disease
14%
High-Fructose Diet
12%
All Cause Mortality
12%
Autophagy
12%
Kidney Function
12%
Nephropathy
12%
Obesity
11%
In Vitro
11%
Diabetes Mellitus
10%
Cerebral Hemorrhage
10%
Retrospective Study
10%
ACE Inhibitor
10%
Endothelial Dysfunction
10%
Patient with Diabetes
10%
Protein Restriction
9%
Fibrosis
9%
Kidney Cell
9%
Injury
9%
Malignant Neoplasm
9%
Glucose Intolerance
9%
Cardiovascular Disease
9%
Breast Tumor
8%
down Regulation
8%
Stenosis
8%
Continuous Hemofiltration
8%
Surgery
8%
Percutaneous Transluminal Angioplasty
8%
Cigarette Smoke
8%
Cell Death
8%
Spontaneous Bacterial Peritonitis
8%
Open Angle Glaucoma
8%
Heat Injury
8%
Systematic Review
8%
Aliskiren
8%
Renin Inhibitor
8%
Ribonuclease
8%
Glucose 6 Phosphate Dehydrogenase
8%
Bacterial Infection
8%
Supplementation
8%
Nursing and Health Professions
Cohort Analysis
54%
Hemodialysis
46%
Hospital Service
21%
Chronic Kidney Failure
17%
Arteriovenous Fistula
17%
Confidence Interval
16%
Hazard Ratio
14%
Coronary Artery Disease
13%
Diabetes Mellitus
11%
Meta Analysis
10%
End Stage Renal Disease
10%
Patient with Diabetes
10%
Case-Control Study
8%
Surgery
8%
Polyunsaturated Fatty Acid
8%
Systematic Review
8%
Heart Rate Variability
8%
Metformin
8%
Retina Blood Vessel Occlusion
8%
Percutaneous Transluminal Angioplasty
8%
Perception Deafness
8%
Protein Restriction
8%
Supplementation
8%
Injury
8%
Fracture
8%
Gout
8%
Heat Stroke
8%
Ischemic Heart Disease
8%
Stenosis
8%
Fistula
6%
Cardiovascular Disease
5%
